Modified version of the American College of Cardiology's recommendation for low-dose prothrombin complex concentrate is effective for warfarin reversal
Author:
Publisher
Elsevier BV
Subject
Emergency Medicine,General Medicine
Reference14 articles.
1. Tomaselli GF, Mahaffey KW, Cuker A, et al. 2017 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the american college of cardiology task force on expert consensus decision pathways. J Am Coll Cardiol.2017 Dec 19;70(24):3042–3067.
2. Guideline for reversal of antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the neurocritical care society and society of critical care medicine;Frontera;Neurocrit Care,2016
3. A systematic review of prothrombin complex concentrate dosing strategies to reverse vitamin K antagonist therapy;Khorsand;Thromb Res,2015
4. Fixed dose prothrombin complex concentrate for the reversal of oral anticoagulation therapy;Junagade;Hematology,2007
5. Fixed versus variable dose of prothrombin complex concentrate for counteracting vitamin K antagonist therapy;Khorsand;Transfus Med,2011
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Evaluation of modified fixed dose four-factor prothrombin complex concentrate for warfarin reversal;Journal of Thrombosis and Thrombolysis;2024-04-06
2. Safety and efficacy of fixed versus variable-dose prothrombin complex concentrate for emergent reversal of vitamin K antagonists: A systematic review and meta-analysis;The American Journal of Emergency Medicine;2024-03
3. Fixed- Versus Variable-Dose Prothrombin Complex Concentrate for the Emergent Reversal of Vitamin K Antagonists: A Systematic Review and Meta-Analysis;Critical Care Medicine;2024-02-14
4. Comparison of outcomes for fixed and weight-based four-factor prothrombin complex concentrate dosing regimens;European Journal of Hospital Pharmacy;2023-09-19
5. Fixed-Dose Factor Eight Inhibitor Bypassing Activity (FEIBA) in the Management of Warfarin-Associated Coagulopathies;Pharmacy;2022-04-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3